Report Detail
Global Injectable HIV Treatment Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4683788 |
- 24 August, 2026 |
- Global |
- 76 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Injectable HIV Treatment market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Injectable HIV treatment refers to long-acting antiretroviral therapies administered through injection, designed to either treat or prevent HIV infection. The most notable example is the combination of cabotegravir and rilpivirine, which is administered once every one or two months for people living with HIV. Another injectable medication, cabotegravir alone, is used for Pre-Exposure Prophylaxis (PrEP) to prevent HIV infection in at-risk individuals.
This report is a detailed and comprehensive analysis for global Injectable HIV Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Injectable HIV Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Injectable HIV Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Injectable HIV Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Injectable HIV Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Injectable HIV Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Injectable HIV Treatment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ViiV Healthcare, Janssen Pharmaceuticals, Gilead Sciences, Theratechnologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Injectable HIV Treatment market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cabotegravir
Rilpivirine
Lenacapavir
Ibalizumab
Other
Market segment by Application
Pre-Exposure Prophylaxis
HIV Treatment
Major players covered
ViiV Healthcare
Janssen Pharmaceuticals
Gilead Sciences
Theratechnologies
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Injectable HIV Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Injectable HIV Treatment, with price, sales quantity, revenue, and global market share of Injectable HIV Treatment from 2021 to 2026.
Chapter 3, the Injectable HIV Treatment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Injectable HIV Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Injectable HIV Treatment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Injectable HIV Treatment.
Chapter 14 and 15, to describe Injectable HIV Treatment sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Injectable HIV Treatment Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Cabotegravir
- 1.3.3 Rilpivirine
- 1.3.4 Lenacapavir
- 1.3.5 Ibalizumab
- 1.3.6 Other
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Injectable HIV Treatment Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Pre-Exposure Prophylaxis
- 1.4.3 HIV Treatment
- 1.5 Global Injectable HIV Treatment Market Size & Forecast
- 1.5.1 Global Injectable HIV Treatment Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Injectable HIV Treatment Sales Quantity (2021-2032)
- 1.5.3 Global Injectable HIV Treatment Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 ViiV Healthcare
- 2.1.1 ViiV Healthcare Details
- 2.1.2 ViiV Healthcare Major Business
- 2.1.3 ViiV Healthcare Injectable HIV Treatment Product and Services
- 2.1.4 ViiV Healthcare Injectable HIV Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 ViiV Healthcare Recent Developments/Updates
- 2.2 Janssen Pharmaceuticals
- 2.2.1 Janssen Pharmaceuticals Details
- 2.2.2 Janssen Pharmaceuticals Major Business
- 2.2.3 Janssen Pharmaceuticals Injectable HIV Treatment Product and Services
- 2.2.4 Janssen Pharmaceuticals Injectable HIV Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Janssen Pharmaceuticals Recent Developments/Updates
- 2.3 Gilead Sciences
- 2.3.1 Gilead Sciences Details
- 2.3.2 Gilead Sciences Major Business
- 2.3.3 Gilead Sciences Injectable HIV Treatment Product and Services
- 2.3.4 Gilead Sciences Injectable HIV Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Gilead Sciences Recent Developments/Updates
- 2.4 Theratechnologies
- 2.4.1 Theratechnologies Details
- 2.4.2 Theratechnologies Major Business
- 2.4.3 Theratechnologies Injectable HIV Treatment Product and Services
- 2.4.4 Theratechnologies Injectable HIV Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Theratechnologies Recent Developments/Updates
3 Competitive Environment: Injectable HIV Treatment by Manufacturer
- 3.1 Global Injectable HIV Treatment Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Injectable HIV Treatment Revenue by Manufacturer (2021-2026)
- 3.3 Global Injectable HIV Treatment Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Injectable HIV Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Injectable HIV Treatment Manufacturer Market Share in 2025
- 3.4.3 Top 6 Injectable HIV Treatment Manufacturer Market Share in 2025
- 3.5 Injectable HIV Treatment Market: Overall Company Footprint Analysis
- 3.5.1 Injectable HIV Treatment Market: Region Footprint
- 3.5.2 Injectable HIV Treatment Market: Company Product Type Footprint
- 3.5.3 Injectable HIV Treatment Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Injectable HIV Treatment Market Size by Region
- 4.1.1 Global Injectable HIV Treatment Sales Quantity by Region (2021-2032)
- 4.1.2 Global Injectable HIV Treatment Consumption Value by Region (2021-2032)
- 4.1.3 Global Injectable HIV Treatment Average Price by Region (2021-2032)
- 4.2 North America Injectable HIV Treatment Consumption Value (2021-2032)
- 4.3 Europe Injectable HIV Treatment Consumption Value (2021-2032)
- 4.4 Asia-Pacific Injectable HIV Treatment Consumption Value (2021-2032)
- 4.5 South America Injectable HIV Treatment Consumption Value (2021-2032)
- 4.6 Middle East & Africa Injectable HIV Treatment Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Injectable HIV Treatment Sales Quantity by Type (2021-2032)
- 5.2 Global Injectable HIV Treatment Consumption Value by Type (2021-2032)
- 5.3 Global Injectable HIV Treatment Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Injectable HIV Treatment Sales Quantity by Application (2021-2032)
- 6.2 Global Injectable HIV Treatment Consumption Value by Application (2021-2032)
- 6.3 Global Injectable HIV Treatment Average Price by Application (2021-2032)
7 North America
- 7.1 North America Injectable HIV Treatment Sales Quantity by Type (2021-2032)
- 7.2 North America Injectable HIV Treatment Sales Quantity by Application (2021-2032)
- 7.3 North America Injectable HIV Treatment Market Size by Country
- 7.3.1 North America Injectable HIV Treatment Sales Quantity by Country (2021-2032)
- 7.3.2 North America Injectable HIV Treatment Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Injectable HIV Treatment Sales Quantity by Type (2021-2032)
- 8.2 Europe Injectable HIV Treatment Sales Quantity by Application (2021-2032)
- 8.3 Europe Injectable HIV Treatment Market Size by Country
- 8.3.1 Europe Injectable HIV Treatment Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Injectable HIV Treatment Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Injectable HIV Treatment Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Injectable HIV Treatment Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Injectable HIV Treatment Market Size by Region
- 9.3.1 Asia-Pacific Injectable HIV Treatment Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Injectable HIV Treatment Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Injectable HIV Treatment Sales Quantity by Type (2021-2032)
- 10.2 South America Injectable HIV Treatment Sales Quantity by Application (2021-2032)
- 10.3 South America Injectable HIV Treatment Market Size by Country
- 10.3.1 South America Injectable HIV Treatment Sales Quantity by Country (2021-2032)
- 10.3.2 South America Injectable HIV Treatment Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Injectable HIV Treatment Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Injectable HIV Treatment Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Injectable HIV Treatment Market Size by Country
- 11.3.1 Middle East & Africa Injectable HIV Treatment Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Injectable HIV Treatment Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Injectable HIV Treatment Market Drivers
- 12.2 Injectable HIV Treatment Market Restraints
- 12.3 Injectable HIV Treatment Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Injectable HIV Treatment and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Injectable HIV Treatment
- 13.3 Injectable HIV Treatment Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Injectable HIV Treatment Typical Distributors
- 14.3 Injectable HIV Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Injectable HIV Treatment. Industry analysis & Market Report on Injectable HIV Treatment is a syndicated market report, published as Global Injectable HIV Treatment Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Injectable HIV Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
